Inventor
SHOKAT KEVAN M
US34 patents
⚠️ This page may combine multiple inventors who share the name “SHOKAT KEVAN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
24 patentsUS10023588B2Jul 17, 2018
Compositions and methods for treating cancer
UNIV CALIFORNIA30 citations96
US7585868B2Sep 8, 2009
Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists
UNIV CALIFORNIA103 citations95
US7429596B2Sep 30, 2008
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
UNIV CALIFORNIA104 citations95
US11008334B2May 18, 2021
Compositions and methods for treating cancer
UNIV CALIFORNIA21 citations93
US9321772B2Apr 26, 2016
Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
UNIV CALIFORNIA46 citations92
US9629843B2Apr 25, 2017
MTOR modulators and uses thereof
UNIV CALIFORNIA18 citations90
US9382230B2Jul 5, 2016
Methods and compositions for modulating Ire1, SRC and ABL activity
UNIV CALIFORNIA16 citations89
US11891402B2Feb 6, 2024
Compositions and methods for treating cancer
UNIV CALIFORNIA3 citations84
US11718630B2Aug 8, 2023
Compositions and methods for treating cancer
UNIV CALIFORNIA4 citations84
US11603376B2Mar 14, 2023
Compositions and methods for treating cancer
UNIV CALIFORNIA6 citations84
US11136297B2Oct 5, 2021
Compositions and methods for treating cancer
UNIV CALIFORNIA6 citations79
US9493467B2Nov 15, 2016
PI3 kinase antagonists
UNIV CALIFORNIA12 citations78
US12116375B2Oct 15, 2024
Compositions and methods for treating cancer
UNIV CALIFORNIA1 citations72
US10723737B2Jul 28, 2020
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
UNIV CALIFORNIA4 citations70
US9353116B2May 31, 2016
Methods and compositions for kinase inhibition
UNIV CALIFORNIA5 citations69
US9895373B2Feb 20, 2018
Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
UNIV CALIFORNIA3 citations68
US12365693B2Jul 22, 2025
Compositions and methods for treating cancer
UNIV CALIFORNIA0 citations61
US11427588B2Aug 30, 2022
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
UNIV CALIFORNIA0 citations59
US12077507B2Sep 3, 2024
Compositions and methods for treating cancer
UNIV CALIFORNIA0 citations58
US12558356B2Feb 24, 2026
Immunophilin binding agents and uses thereof
UNIV CALIFORNIA0 citations56
US11208411B2Dec 28, 2021
Compositions and methods for treating parasitic diseases
UNIV CALIFORNIA0 citations55
US12551482B2Feb 17, 2026
Aurora kinase inhibitors
UNIV CALIFORNIA0 citations53
US11135222B2Oct 5, 2021
Aurora kinase inhibitors
UNIV CALIFORNIA1 citations53
US12486334B2Dec 2, 2025
Chemically controlled monoclonal antibody target engagement
UNIV CALIFORNIA0 citations46
UNIV PRINCETON
5 patentsUS7049116B2May 23, 2006
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
UNIV PRINCETON89 citations99
US6521417B1Feb 18, 2003
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
UNIV PRINCETON95 citations99
US6390821B1May 21, 2002
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
UNIV PRINCETON114 citations99
US6383790B1May 7, 2002
High affinity protein kinase inhibitors
UNIV PRINCETON213 citations99
US6610483B1Aug 26, 2003
Methods for identifying cellular responses attributable to signaling molecule inhibition and inhibitors thereof
UNIV PRINCETON4 citations60